"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Xilio Therapeutics Announces Initial Clinical Trial Data from Phase 1C Dose Escalation for Vilastobart (XTX101)
Ruben Mesa Highlights CancerX Accelerator Jam 2025 and Startup Innovations
Chinese Cancer Drug Set to Transform Global Market: Glecirasib | Most Promising Cancer Drugs 2024
Osteopontin as a therapeutic target in Breast Cancer recurrence
15 Posts Not to Miss from ESMO TAT Asia 2025
Vinay Prasad Rejoins FDA Days After Exit
